Chlorhexidine Bathing Effect on Clostridium Difficile Rates
Effect of Daily Chlorhexidine Bathing on Clostridium Difficile Rates on the General Medical Floor in Patients Receiving Antibiotics
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Illinois
-
Geneva, Illinois, United States, 60134
- Northwestern Medicine - Delnor Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Prescription of antibiotics for suspected or confirmed infection.
- Admitted to the 2600 General/Medical ward at Delnor Hospital.
Exclusion Criteria:
- Antibiotics only for surgical prophylaxis
- Not mentally capable
- Cannot provide consent in English
- Pregnant
- Documented chlorhexidine allergy
- Patient is a prisoner
- Health system employee
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control
Receive the bathing standard of care.
|
|
|
Experimental: Interventional
Receive daily bathing with 2% Chlorhexidine gluconate bathing wipes.
|
Daily bathing.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with Relative Risk of C-diff infection
Time Frame: up to 12 months
|
Study data will cease to be collected after 300 participants have been enrolled or until 12 months have elapsed.
Data will be collected and assessed monthly.
|
up to 12 months
|
|
Duration of Hospital stays
Time Frame: expected average of six days
|
expected average of six days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Brian Poustinchian, D.O., Hospitalist - Northwestern Medicine Regional Medical Group
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CDiff070115
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.